Background: Altered diastolic filling is an important contributor to several cardiovascular disorders. Multiple lines of evidence suggest a genetic contribution to left ventricular (LV) diastolic filling; however, chromosomal locations harboring genes involved in impaired LV diastolic filling have not been reported. The aim of this study was to identify chromosomal regions contributing to variation of LV transmitral early and late peak filling velocities (E and A velocities), Doppler echocardiographic measures of LV diastolic filling.
Background: Altered diastolic filling is an important contributor to several cardiovascular disorders. Multiple lines of evidence suggest a genetic contribution to left ventricular (LV) diastolic filling; however, chromosomal locations harboring genes involved in impaired LV diastolic filling have not been reported. The aim of this study was to identify chromosomal regions contributing to variation of LV transmitral early and late peak filling velocities (E and A velocities), Doppler echocardiographic measures of LV diastolic filling.
Methods:
We adjusted E and A velocities for age, age squared, heart rate, body mass index, systolic blood pressure, field center, and antihypertensive medication in sexand ethnicity-specific linear regression models. Standardized residuals were calculated and used in multipoint variance components linkage analysis (GENEHUNTER). Anonymous markers (Cooperative Human Linkage Center set 8) were available for 167 white hypertensive sibships (397 subjects, mean age 60 years) and 182 African American (393 subjects, mean age 52 years) hypertensive sibships.
Results: For E velocity, linkage was detected on chromosome 5 at 133.6 centimorgan (cM) in African Americans (logarithm of the odds [LOD] ϭ 4.13), and suggestive linkage (LOD Ͼ1.9) was observed for regions on chromosome 10 (80.8 cM) and chromosome 20 (1.5 cM). For A velocity, suggestive linkage was found for chromosome 12 (GATA85A04) in whites and for chromosome 8 (122.9 cM) in African Americans. Genes contained in and around the linked region are important candidates for diastolic filling (calcium-modulating cyclophilin ligand A bnormal diastolic filling is the presumed mechanism in approximately 50% of cases of congestive heart failure. [1] [2] [3] [4] Furthermore, abnormal diastolic filling is an important contributor to symptoms in patients with systolic dysfunction and a number of other common cardiovascular disorders. 5 The identification of genes or genetic pathways that predispose to diastolic dysfunction in humans may offer strategies for prevention and open new avenues for treatment.
Evidence from studies in animals and humans show that interindividual variation in LV diastolic function is under genetic control. 6 -8 Changes in the transcription and protein expression of various genes, including SR-Ca 2ϩ ATPase pump, 6 occur in congestive heart failure. Phos-pholamban overexpression prolongs isovolumic relaxation and increases left ventricular (LV) end-diastolic pressure in rats. 7 Diastolic filling parameters are associated with the angiotensin converting enzyme I/D 9 and G-protein ␤3 subunit C825T gene polymorphisms. 10 We recently reported that in the population-based HyperGEN Study, the heritabilities 11 were significant at about 0.50 for Doppler LV diastolic filling indices, transmitral early and late peak filling velocities. 12 The present study reports results from a genome-wide scan in African American and white hypertensive sibships to identify chromosomal regions contributing to the variation of transmitral LV diastolic filling parameters in the same study population.
Methods

Study Population
Subjects were participants of the Family Blood Pressure Program (FBPP) Hypertension Genetic Epidemiology Network (HyperGEN)-Genetics of Left Ventricular Hypertrophy Study. HyperGEN is one of four networks initiated and supported by the National Heart, Lung, and Blood Institute to identify genetic contributions to hypertension. 13 Hypertensive sibships were ascertained through population-based cohorts or from the community at large, and random subjects were recruited from the same field center catchment area as hypertensive siblings without regard to their hypertension status. Probands were identified by onset of hypertension by age 60 years and the presence of at least one additional hypertensive sibling who was willing to participate. Hypertension was defined as systolic BP (SBP) Ն140 mm Hg or diastolic BP Ն90 mm Hg on at least two different evaluations, or treatment for hypertension. Volunteers with type 1 diabetes or renal failure were excluded to remove potential secondary causes of hypertension. The Genetics of Left Ventricular Hypertrophy Study, an ancillary study to HyperGEN, performed echocardiography in four of five centers in Hyper-GEN (Minneapolis, MN; Salt Lake City, UT; Forsyth County, NC; and Birmingham, AL). African American subjects were recruited in Birmingham and Forsyth County, whereas white subjects were recruited in Forsyth County, NC, and Salt Lake City, UT. Included in the current analysis are 182 African American and 167 white sibships, ranging from two to six individuals (Table 1) . No participant was excluded based on LV filling measures.
Diastolic Filling Parameters
Two-dimensionally guided M-mode, two-dimensional (2D), and Doppler echocardiography was performed by a standardized protocol 14 developed at the Echocardiography Reading Center at the New York Hospital-Cornell Medical Center. Certified sonographers were selected by Field Center investigators and trained at the Echocardiography Reading Center. Correct orientation of planes for imaging and Doppler recordings was verified using standard procedures.
14 Measurements were made using a computerized review station with a digitizing tablet and monitor screen overlay for calibration and performance of measurements (Digisonics, Inc., Houston, TX). Readings were first made by experienced sonographer or physician readers and verified by highly experienced cardiologists in the reading center for accuracy and reproducibility.
Left ventricular diastolic filling parameters were measured by pulsed Doppler in apical four-chamber view during diastole, with the sample volume placed at mitral valve leaflet tips or mitral valve annulus. Transmitral early peak filling velocity (E velocity) and atrial phase peak filling velocity (A velocity), deceleration time of early diastolic filling, and the isovolumic relaxation time (IVRT) were measured as previously described. 15 Because the E and A velocities showed higher heritabilites (h 2 ϭ 0.52 and 0.50) than the deceleration time or IVRT (h 2 ϭ 0.12 and 0.38), 12 genetic analyses focused on the former measures of diastolic LV filling. As 60% of subjects had diastolic filling measurements available at the leaflet tips, and the rest had those measurements available at the annulus, the following equations, derived from 725 hypertensive patients enrolled in the Losartan Intervention for Endpoint (LIFE) trial, 16 were used to convert diastolic filling parameters at the annulus to those at the leaflet tips when leaflet tip measurements were missing, as follows: E at the tips ϭ 0.84*E at the annulus ϩ 23.3; and A at the tips ϭ 0.76*A at the annulus ϩ 28.9.
Estimated E and A velocities showed good correlation with observed values both at enrollment in LIFE, when patients were untreated (r ϭ 0.67 for both E and A velocities, P Ͻ .0001), 16 and after 12 months of treatment (E velocity: r ϭ 0.61, P Ͻ .0001, mean difference ϭ 0.02 m/sec; A velocity: r ϭ 0.60, P Ͻ .0001, mean difference ϭ 0.01 m/sec) (Devereux RB et al, unpublished data). Left ventricular mass was calculated as previously described 14 and was indexed for body mass area. Left ventricular systolic function was evaluated by ejection fraction and stress-corrected midwall shortening. 15 Reproducibility of LV measurements between separate echocardiograms by methods similar to those used in HyperGEN has been recently reported by the reading center (eg, intraclass correlation coefficients r i ϭ 0.93 for LV mass, 0.58 for E velocity, 0.57 for A velocity).
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Genotyping
Genotyping was carried out using short tandem repeat polymorphisms by the National Heart, Lung, and Blood Institute Mammalian Genotyping Service (Marshfield, WI). (For additional information regarding genotyping methods, see the Marshfield web site. 18 ) In brief, the genotype was determined by means of an automated technique using polymerase chain reaction and the SCAnning FlUorescence Detector (SCAFUD). The Cooperative Human Linkage Center Screening set 8 was used, which includes 387 microsatellite markers spaced about every 9 cM throughout the genome. The average marker heterozygosity was 0.76. Analyses and assignment of marker alleles were done using computerized algorithms. Marker consistency with Mendelian expectations between siblings was tested using affected sib-pair exclusion mapping, 19 a likelihood-based method. Only confirmed sibs with marker compatibility were used in the linkage analysis.
Statistical Adjustments
To reduce the influence of preload and afterload conditions and other nongenetic sources of variation, E and A velocities were statistically adjusted for the effects of age, age squared (to adjust for nonlinearity of relations with age), heart rate, body mass index (BMI), SBP, field center, and antihypertensive medication class (angiotensin converting enzyme inhibitors, ␤-blockers, Ca 2ϩ channel blockers, diuretics, and others) in sex-and ethnicity-specific linear regression models. Residuals from these regression models were retained for subsequent linkage analysis. In the regression models, these covariates collectively contributed to 9.0% (African American women), 7.5% (African American men), 11.0% (white women), and 4.8% (white men) of variation in E velocity, and to 21.8% (African American women), 14.5% (African American men), 25.2% (white women), and 23.4% (white men) of variation in A velocity. The fully adjusted model was compared with a minimally adjusted model in which E and A velocities were regressed only on age and age squared.
Multipoint Linkage Analysis
A multipoint variance-component approach implemented in GENEHUNTER version 2.0 20 was used to examine evidence for linkage of E and A velocities as continuous variables. The full probability distribution of allele sharing at every point in a mapped region was estimated with an exact multipoint algorithm. 20 Variance components due to additive and dominant genetic contributions of a major quantitative trait locus, residual additive and dominant genetic effects, and environmental effects were estimated by a maximum likelihood method at each marker locus. Significance of a genetic contribution of the quantitative trait locus was tested by comparing the maximum likelihood of the full model to that of a reduced model that constrains the quantitative trait locus components to be zero. The difference between the two log likelihoods produced a LOD score equivalent to the classical LOD score in linkage analysis. The phenotypes used in reported linkage analyses were standardized residuals of A (both ethnic groups) and E velocities (African Americans), and the square root of 50 plus the E velocity residual (whites) to normalize the skewed distribution of E velocity residual in whites. The distribution of the four final phenotypes was compatible with a normal distribution in each ethnic group (P Ͼ .05 for Shapiro-Wilk test of normality). Allele frequencies were estimated based on marker allele frequencies of the random sample in each ethnic group separately (191 white and 99 African American subjects). Genome scans were conducted separately for each ethnic group. Table 2 shows the phenotypic characteristics of participants stratified by sex and ethnicity. In this hypertensive sample, mean E and A velocities were higher in African American women and men than in white participants of the same sex. The E/A ratio was higher and IVRT lower in African Americans than in whites in each sex group (P Ͻ .05). However, the ethnicity-related differences in E/A and IVRT were no longer significant after adjustment for age. Both SBP and LV mass index were higher in African Americans than in whites.
Results
The linkage results with peak LOD scores Ͼ1.9 for E and A velocities are presented in Table 3 . The minimally and fully adjusted residual models yielded similar results for peak LOD positions. For E velocity, the highest LOD score was 4.13 from the fully adjusted model in African Americans on chromosome 5 at 133.6 cM, between markers D5S1505 (LOD ϭ 3.14) and D5S816 (LOD ϭ 2.94). The 1-LOD unit support interval of 9 cM extends from 129 cM to 138 cM (Fig. 1) . This locus explains 70.5% of total phenotypic variation in E velocity. No comparable peak was observed in whites. Two additional locations, marker D10S1225 (chromosome 10) and a locus between GATA51D03 and D20S103 (chromosome 20), also had LOD scores Ͼ1.9 in African Americans for the fully adjusted model.
For peak A velocity, the best evidence for linkage was found using the fully adjusted model in African Americans on chromosome 8 with a peak LOD score of 2.33 at position 122.9 cM; about 60% of the phenotypic variance was explained by this locus. Marker GATA85A04 on chromosome 12 also showed suggestive evidence for linkage in whites (LOD ϭ 2.13). The variance components estimates from GENEHUNTER 2.0 are listed in Table 3 . For deceleration time and IVRT, no evidence for linkage was observed at regions significantly or suggestively mapped to E or A velocities. Instead, they were weakly linked to dissimilar chromosomal locations (IVRT: LOD The genes encoding calcium-modulating cyclophilin ligand (CAMLG) and ␣-1B adrenergic receptor (ADRA1B) cluster within the region on chromosome 5 where the highest LOD score for E velocity was obtained. SBP ϭ systolic blood pressure; Anti-HT meds ϭ antihypertensive medications; HT ϭ hypertension; E velocity ϭ LV transmitral early peak filling velocity; A velocity ϭ LV transmitral atrial phase peak filling velocity; LV ϭ left ventricular; IVRT ϭ isovolumic relaxation time; MWS ϭ midwall shortening; LVMI ϭ LV mass indexed to body surface area; CVD ϭ cardiovascular diseases; ACE ϭ angiotensin converting enzyme; EF ϭ ejection fraction. * P Ͻ .05 for comparison of means between ethnicities. † P Ͻ .05 for comparison of means between sexes. ‡ Low ejection fraction: EF Ͻ52% in men and Ͻ55% in women; low stress-corrected MWS: MWS Ͻ88% in men and Ͻ89% in women. LOD ϭ logarithm of the odds; QTL ϭ quantitative trait locus; cM ϭ centimorgan; Va ϭ variation from additive effects of alleles; Vd ϭ variation from dominant effects of alleles; Full ϭ fully adjusted residual model (age, age 2 , heart rate, body mass index, SBP, field center and antihypertensive medication); Min ϭ minimally adjusted residual model (age and age 2 ); AA ϭ African Americans; Wh ϭ whites; other abbreviations as in Table 2 .
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The flanking markers for the peak LOD score, the corresponding candidate genes, and their locations in LDB map 21 are shown in Table 4 .
Discussion
To our knowledge, this is the first report of evidence for genetic linkage of Doppler transmitral early and late diastolic peak filling velocities in humans. Variance components methods identified a locus at 133.6 cM on chromosome 5 (5q23) that shows evidence for a major gene contributing to E velocity in African Americans. We also identified several other regions with modest evidence for linkage suggesting other genomic regions may contain genes influencing diastolic filling. To reduce nongenetic sources of variation from other pathways unrelated to diastolic function, we adjusted the E and A velocities for preload (heart rate) and afterload (SBP), and other demographic and anthropometric variables. In addition, LV diastolic filling curves are changed by antihypertensive treatment. 5 Therefore, we included antihypertensive drug classes in the adjustment model to remove their influence. However, the positions of the peak LOD scores between the minimally and fully adjusted models are consistent within the reported standard error of the location estimates, 22 although the fully adjusted residual model yields stronger genetic evidence.
Two candidate genes, CAMLG and ADRA1B, reside in the 1-LOD support interval on chromosome 5q23-32 where the best evidence for linkage was obtained. CAMLG is an integral membrane protein involved in the regulation of Ca 2ϩ signaling in T lymphocytes. 23 It colocalizes with sacroplasmic/endoplasmic reticulum Ca 2ϩ -
FIG. 1.
Results of the multipoint linkage analysis for E velocity for African Americans and whites on chromosome 5. Each scanned marker is given at its respective cM position along the x-axis from the p-telomere (left) to the q-telomere (right). cM ϭ centimorgan; LOD ϭ logarithm of the odds; E velocity ϭ left ventricular transmitral early peak filling velocity; Full ϭ fully adjusted; min ϭ minimally adjusted. Minimally adjusted ϭ adjustment for age and age 2 . Fully adjusted ϭ adjustment for age, age 2 , field center, heart rate, body mass index, systolic blood pressure, and antihypertensive medication class. ATPase2 at membrane-bound cytosolic vesicles, and its overexpression leads to marked depletion of intracellular Ca 2ϩ stores. 24 The CAMLG may play a role in Ca 2ϩ transport in the myocardial contraction/relaxation cycle because it is expressed in multiple tissues. 23 The ADRA1B gene is expressed in the myocardium. 25 ␣-1 adrenergic receptors, including ␣-1A and ␣-1B, participate in modulation of cardiac function. 26 Coupled with G protein, they indirectly stimulate intracellular calcium release and protein kinase C activation. 27 Activation of ␣-1 adrenergic receptors also results in release of atrial natriuretic factor, a marker for severity of congestive heart failure. 28, 29 We report dissimilar findings in the two ethnic groups. The differences may be explained if allelic variants occur in the two groups in different frequencies, yielding a detectable signal if the allele frequency is sufficiently large. An alternative possibility is that of genetic heterogeneity in the underlying pathophysiology of altered diastolic filling. Cardiac dysfunction may arise through different pathways, with different effects of genetic loci, environmental factors, and gene-environment interactions between ethnic groups. Specifically, sympathetic activity has been associated with congestive heart failure, and African Americans have higher sympathetic response to cold stress than do whites. 30 In view of exclusive identification of the region containing ADRA1B gene in African Americans, it is tempting to speculate that genetic variants in ADRA1B that contribute to higher sympathetic activity and, therefore modulate LV early diastolic relaxation, may be more prevalent in African Americans.
Study Limitations
Although E and A velocities were our primary phenotypes for diastolic filling, there are limitations in the measurement of these indexes. Doppler filling velocities are altered by afterload, preload, heart rate, age, and medications. 5, [31] [32] [33] To reduce these influences, the following were done: 1) echocardiographic measurements were obtained at quiet, supine rest, under euvolumic conditions with standardized protocol; and 2) E and A velocities were adjusted for these covariates in regression models to reduce nongenetic sources of variation. Less load-dependent measures, such as IVRT and E deceleration time, revealed lower broad-sense heritabilities and weaker evidence for genetic linkage. The second limitation is use of regression equation to correct for mitral sample volume position. When restricting the analysis to E velocity obtained at the tips of the leaflets in 60% of the study population, we obtained similar trend but weaker peak LOD score on chromosome 5 (LOD ϭ 0.6 at 133.6 cM in African Americans). The decrease in genetic signal is likely due to loss of power, as 54% of sibships (55% of individuals) were excluded from the subgroup analysis (that is, only families containing at least two siblings contribute to genome scan).
Conclusions
In conclusion, in this study we found significant evidence for the presence of a genetic locus on chromosome 5q23 linked to peak E wave velocity in African Americans. The location of peak LOD score is in close proximity to the CAMLG and ADRA1B genes, which play significant roles in modulation of Ca 2ϩ transport.
